These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8382597)

  • 1. Differential promoter activation in two human insulin-like growth factor-II-producing tumor cell lines.
    Schneid H; Holthuizen PE; Sussenbach JS
    Endocrinology; 1993 Mar; 132(3):1145-50. PubMed ID: 8382597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutive or inducible overexpression of the IGF-2 gene in cells of a human colon carcinoma cell line.
    Lamonerie T; Lavialle C; de Galle B; Binoux M; Brison O
    Exp Cell Res; 1995 Feb; 216(2):342-51. PubMed ID: 7531153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Egr-1 mediates transcriptional activation of IGF-II gene in response to hypoxia.
    Bae SK; Bae MH; Ahn MY; Son MJ; Lee YM; Bae MK; Lee OH; Park BC; Kim KW
    Cancer Res; 1999 Dec; 59(23):5989-94. PubMed ID: 10606246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human hepatitis B virus transactivator X gene product regulates Sp1 mediated transcription of an insulin-like growth factor II promoter 4.
    Lee YI; Lee S; Lee Y; Bong YS; Hyun SW; Yoo YD; Kim SJ; Kim YW; Poo HR
    Oncogene; 1998 May; 16(18):2367-80. PubMed ID: 9620554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postnatal liver-specific expression of human insulin-like growth factor-II is highly stimulated by the transcriptional activators liver-enriched activating protein and CCAAT/enhancer binding protein-alpha.
    Rodenburg RJ; Teertstra W; Holthuizen PE; Sussenbach JS
    Mol Endocrinol; 1995 Apr; 9(4):424-34. PubMed ID: 7659086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of the human, mouse and rat IGF-II genes.
    Holthuizen PE; Cleutjens CB; Veenstra GJ; van der Lee FM; Koonen-Reemst AM; Sussenbach JS
    Regul Pept; 1993 Oct; 48(1-2):77-89. PubMed ID: 8265819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor-II expression in carcinoma in colon cell lines: implications for autocrine actions.
    Guo YS; Jin GF; Townsend CM; Zhang T; Sheng HM; Beauchamp RD; Thompson JC
    J Am Coll Surg; 1995 Aug; 181(2):145-54. PubMed ID: 7627387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogene-induced up-regulation of Caco-2 cell proliferation involves IGF-II gene activation through a protein kinase C-mediated pathway.
    Cadoret A; Baron-Delage S; Bertrand F; Kornprost M; Groyer A; Gespach C; Capeau J; Cherqui G
    Oncogene; 1998 Aug; 17(7):877-87. PubMed ID: 9780004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Nardone G; Romano M; Calabrò A; Pedone PV; de Sio I; Persico M; Budillon G; Bruni CB; Riccio A; Zarrilli R
    Hepatology; 1996 Jun; 23(6):1304-12. PubMed ID: 8675143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypomethylated P4 promoter induces expression of the insulin-like growth factor-II gene in hepatocellular carcinoma in a Chinese population.
    Tang SH; Yang DH; Huang W; Zhou HK; Lu XH; Ye G
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4171-7. PubMed ID: 16857788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter-specific transcription of insulin-like growth factor-II in epithelial ovarian cancer.
    Lu L; Katsaros D; Wiley A; Rigault de la Longrais IA; Puopolo M; Schwartz P; Yu H
    Gynecol Oncol; 2006 Dec; 103(3):990-5. PubMed ID: 16859738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the insulin-like growth factor II transcription by aflatoxin B1 induced p53 mutant 249 is caused by activation of transcription complexes; implications for a gain-of-function during the formation of hepatocellular carcinoma.
    Lee YI; Lee S; Das GC; Park US; Park SM; Lee YI
    Oncogene; 2000 Aug; 19(33):3717-26. PubMed ID: 10949925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation between epigenetic alterations in the insulin growth factor-II gene and hepatocellular carcinoma].
    Dong ZZ; Yao DF; Wu W; Qiu LW; Yao NH; Yan XD; Yu DD; Chen J
    Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):593-7. PubMed ID: 23207153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the IGF-II gene by HBV-X protein requires PKC and p44/p42 map kinase signalings.
    Kang-Park S; Lee JH; Shin JH; Lee YI
    Biochem Biophys Res Commun; 2001 May; 283(2):303-7. PubMed ID: 11327698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disrupted IGF2 promoter control by silencing of promoter P1 in human hepatocellular carcinoma.
    Li X; Nong Z; Ekström C; Larsson E; Nordlinder H; Hofmann WJ; Trautwein C; Odenthal M; Dienes HP; Ekström TJ; Schirmacher P
    Cancer Res; 1997 May; 57(10):2048-54. PubMed ID: 9158004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of imprinting of the insulin-like growth factor II gene in mouse hepatocellular carcinoma cell lines.
    Ooasa T; Karasaki H; Kanda H; Nomura K; Kitagawa T; Ogawa K
    Mol Carcinog; 1998 Dec; 23(4):248-53. PubMed ID: 9869454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus core protein transactivates insulin-like growth factor II gene transcription through acting concurrently on Egr1 and Sp1 sites.
    Lee S; Park U; Lee YI
    Virology; 2001 May; 283(2):167-77. PubMed ID: 11336542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of the insulin-like growth factor-1 receptor and autocrine stimulation in human cervical cancer cells.
    Steller MA; Delgado CH; Bartels CJ; Woodworth CD; Zou Z
    Cancer Res; 1996 Apr; 56(8):1761-5. PubMed ID: 8620490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a teleost insulin-like growth factor II (IGF-II) gene: evidence for promoter CCAAT/enhancer-binding protein (C/EBP) sites, and the presence of hepatic C/EBP.
    Shamblott MJ; Leung S; Greene MW; Chen TT
    Mol Mar Biol Biotechnol; 1998 Sep; 7(3):181-90. PubMed ID: 9701612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of insulin-like growth factor II P3 promotor by p53: a potential mechanism for tumorigenesis.
    Zhang L; Kashanchi F; Zhan Q; Zhan S; Brady JN; Fornace AJ; Seth P; Helman LJ
    Cancer Res; 1996 Mar; 56(6):1367-73. PubMed ID: 8640827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.